PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
21.62%
Growth of 21.62% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-25.74%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
39.20%
Growth of 39.20% versus flat Healthcare gross profit. Walter Schloss would verify quality.
14.45%
Margin change of 14.45% versus flat Healthcare margins. Walter Schloss would verify quality.
38.52%
R&D change of 38.52% versus flat Healthcare spending. Walter Schloss would verify adequacy.
111.30%
G&A change of 111.30% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
6.88%
Marketing expense change of 6.88% versus flat Healthcare spending. Walter Schloss would verify adequacy.
17.25%
Other expenses change of 17.25% versus flat Healthcare costs. Walter Schloss would verify efficiency.
72.86%
Operating expenses growth exceeding 1.5x Healthcare median of 0.54%. Jim Chanos would check for waste.
49.34%
Total costs growth exceeding 1.5x Healthcare median of 0.78%. Jim Chanos would check for waste.
6.22%
Interest expense change of 6.22% versus flat Healthcare costs. Walter Schloss would verify control.
94.53%
D&A growth exceeding 1.5x Healthcare median of 1.05%. Jim Chanos would check for overinvestment.
141.87%
EBITDA growth exceeding 1.5x Healthcare median of 0.37%. Joel Greenblatt would investigate advantages.
-128.08%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-255.04%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-191.92%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
168.55%
Other expenses change of 168.55% versus flat Healthcare. Walter Schloss would verify control.
153.87%
Income change of 153.87% versus flat Healthcare. Walter Schloss would verify quality.
108.74%
Margin change of 108.74% versus flat Healthcare. Walter Schloss would verify quality.
1281.17%
Tax expense change of 1281.17% versus flat Healthcare. Walter Schloss would verify strategy.
102.01%
Income change of 102.01% versus flat Healthcare. Walter Schloss would verify quality.
66.09%
Margin change of 66.09% versus flat Healthcare. Walter Schloss would verify quality.
60.99%
EPS growth exceeding 1.5x Healthcare median of 3.19%. Joel Greenblatt would investigate advantages.
101.35%
Diluted EPS growth exceeding 1.5x Healthcare median of 3.13%. Joel Greenblatt would investigate advantages.
16.05%
Share count reduction below 50% of Healthcare median of 0.15%. Jim Chanos would check for issues.
14.82%
Diluted share reduction below 50% of Healthcare median of 0.20%. Jim Chanos would check for issues.